{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:53:26Z","timestamp":1791928406865,"version":"4.3.4"},"reference-count":271,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20242045"],"award-info":[{"award-number":["GZC20242045"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20401"],"award-info":[{"award-number":["U23A20401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422014"],"award-info":[{"award-number":["82422014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.apsb.2026.01.018","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:29:28Z","timestamp":1769128168000},"page":"1250-1271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver\u2013pancreas communication in disease and drug development"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-9842","authenticated-orcid":false,"given":"Yan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-4190","authenticated-orcid":false,"given":"Jia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.01.018_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2013.04.005","article-title":"Underestimation of liver-related mortality in the United States","volume":"145","author":"Asrani","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12963-021-00249-0","article-title":"Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death","volume":"19","author":"Sheu","year":"2021","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.apsb.2026.01.018_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10654-023-01028-x","article-title":"Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019","volume":"38","author":"Nasr","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11427-024-2722-2","article-title":"Epidemiology of liver diseases: global disease burden and forecasted research trends","volume":"68","author":"Xiao","year":"2025","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib6","article-title":"Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021","volume":"12","author":"He","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.apsb.2026.01.018_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990\u20132021 to 2045","volume":"30","author":"Kan","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib8","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2024.04.007","article-title":"EASL position paper on clinical follow-up after HCV cure","volume":"81","author":"Reiberger","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.018_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12876-024-03481-8","article-title":"Global and regional burden of pancreatitis: epidemiological trends, risk factors, and projections to 2050 from the global burden of disease study 2021","volume":"24","author":"Li","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-025-13597-z","article-title":"Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apsb.2026.01.018_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.14309\/ajg.0000000000002081","article-title":"Acute pancreatitis recurrences augment long-term pancreatic cancer risk","volume":"118","author":"Munigala","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.01.018_bib18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.018_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-024-01613-x","article-title":"Consensus, debate, and prospective on pancreatic cancer treatments","volume":"17","author":"Wang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.01.018_bib20","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1097\/JS9.0000000000000877","article-title":"Pancreatic cancer: new approaches to drug therapy","volume":"110","author":"Picozzi","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.apsb.2026.01.018_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.gastro.2023.03.236","article-title":"Distinct serum immune profiles define the spectrum of acute and chronic pancreatitis from the multicenter prospective evaluation of chronic pancreatitis for epidemiologic and translational studies (PROCEED) study","volume":"165","author":"Lee","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-022-01766-4","article-title":"Acute pancreatitis: diagnosis and treatment","volume":"82","author":"Szatmary","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2026.01.018_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.gastro.2024.02.052","article-title":"Diagnosis and management of acute pancreatitis","volume":"167","author":"Trikudanathan","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib24","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(24)02187-1","article-title":"Chronic pancreatitis","volume":"404","author":"Thierens","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.018_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-070920","article-title":"Management of chronic pancreatitis","volume":"384","author":"Hines","year":"2024","journal-title":"Br Med J"},{"key":"10.1016\/j.apsb.2026.01.018_bib26","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.01.018_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.07.007","article-title":"Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib28","article-title":"Cardiac urea cycle activation by time-restricted feeding protects against pressure overload-induced heart failure","volume":"11","author":"Tan","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2026.01.018_bib29","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s00125-020-05203-7","article-title":"Organisation of the human pancreas in health and in diabetes","volume":"63","author":"Atkinson","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/en.2016-1748","article-title":"Insulin and glucagon: partners for life","volume":"158","author":"Holst","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2026.01.018_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155142","article-title":"Insulin: the master regulator of glucose metabolism","volume":"129","author":"Norton","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2026.01.018_bib32","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","article-title":"100 years of glucagon and 100 more","volume":"66","author":"Wewer Albrechtsen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2020.11.009","article-title":"Organ-on-a-chip: a new paradigm for drug development","volume":"42","author":"Ma","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.tem.2024.11.013","article-title":"Inter-organ communication is a critical machinery to regulate metabolism and aging","volume":"36","author":"Tokizane","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1242\/dev.128.6.871","article-title":"A bipotential precursor population for pancreas and liver within the embryonic endoderm","volume":"128","author":"Deutsch","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.apsb.2026.01.018_bib36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1152\/physrev.00003.2021","article-title":"The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas","volume":"101","author":"Petersen","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3727\/105221618X15216414278706","article-title":"Liver and pancreas: do similar embryonic development and tissue organization lead to similar mechanisms of tumorigenesis?","volume":"18","author":"Ghurburrun","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.apsb.2026.01.018_bib38","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.3390\/jcm9103309","article-title":"Pancreatitis associated with viral hepatitis: systematic review","volume":"9","author":"Panic","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib39","article-title":"Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib40","article-title":"Association between hepatitis B or hepatitis C virus infection and risk of pancreatic cancer: a systematic review and meta-analysis of cohort studies","volume":"10","author":"Zhao","year":"2023","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.apsb.2026.01.018_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12985-017-0905-3","article-title":"A preliminary analysis of hepatitis C virus in pancreatic islet cells","volume":"14","author":"Blackard","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2026.01.018_bib42","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1200\/JCO.2008.17.3526","article-title":"Association between hepatitis B virus and pancreatic cancer","volume":"26","author":"Hassan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.01.018_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/jpm12010083","article-title":"Risk factors for pancreatic cancer: emerging role of viral hepatitis","volume":"12","author":"Gheorghe","year":"2022","journal-title":"J Personalized Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib44","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3748\/wjg.v19.i26.4234","article-title":"Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies","volume":"19","author":"Xu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrgastro.2017.172","article-title":"Extrahepatic cancers and chronic HCV infection","volume":"15","author":"Pol","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/hepr.13672","article-title":"Pancreas stiffness in liver cirrhosis is an indicator of insulin secretion caused by portal hypertension and pancreatic congestion","volume":"51","author":"Imamura","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.apsb.2026.01.018_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pan.2019.11.002","article-title":"Clinical outcomes of acute pancreatitis in patients with cirrhosis","volume":"20","author":"Simons-Linares","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib49","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.12998\/wjcc.v9.i34.10418","article-title":"Liver injury associated with acute pancreatitis: the current status of clinical evaluation and involved mechanisms","volume":"9","author":"Liu","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.apsb.2026.01.018_bib50","article-title":"Pancreatic stone protein in patients with liver failure: a prospective pilot cohort study","volume":"44","author":"Lopes","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00046-19","article-title":"Hepatitis B virus: advances in prevention, diagnosis, and therapy","volume":"33","author":"Nguyen","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/microorganisms12061035","article-title":"Contemporary insights into hepatitis C virus: a comprehensive review","volume":"12","author":"Sallam","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.apsb.2026.01.018_bib53","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1093\/cid\/ciad344","article-title":"Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: a narrative review","volume":"77","author":"Martinello","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2026.01.018_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3350\/cmh.2024.0835","article-title":"Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000\u20132021","volume":"31","author":"Danpanichkul","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib55","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib56","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12889-025-22026-6","article-title":"Global, regional and national burden of liver cancer 1990\u20132021: a systematic analysis of the global burden of disease study 2021","volume":"25","author":"Jiang","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.apsb.2026.01.018_bib57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib59","article-title":"Type 1 diabetes: global prevalence is set to double by 2040, study estimates","volume":"378","author":"Mahase","year":"2022","journal-title":"Br Med J"},{"key":"10.1016\/j.apsb.2026.01.018_bib60","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC202406180","article-title":"Type 2 diabetes","volume":"177","author":"Crawford","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib61","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.018_bib62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00125-015-3862-7","article-title":"Inter-organ communication and regulation of beta cell function","volume":"59","author":"Hussain","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib63","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib64","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.7150\/thno.55795","article-title":"Organ\u2013organ communication: the liver's perspective","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.01.018_bib65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: deciphering communication from the liver","volume":"44","author":"Jensen-Cody","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.apsb.2026.01.018_bib68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib69","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","article-title":"FGF21 agonists: an emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond","volume":"81","author":"Harrison","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib70","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.molmet.2017.08.004","article-title":"Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury","volume":"6","author":"Desai","year":"2017","journal-title":"Mol Metabol"},{"key":"10.1016\/j.apsb.2026.01.018_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155616","article-title":"Renoprotective effects of genetically proxied fibroblast growth factor 21: mendelian randomization, proteome-wide and metabolome-wide association study","volume":"145","author":"Giontella","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2026.01.018_bib72","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib73","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2009.07.064","article-title":"Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice","volume":"137","author":"Johnson","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00125-022-05822-2","article-title":"Pancreatic alpha cell glucagon\u2013liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes","volume":"66","author":"Cui","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115928","article-title":"Berberine protects mice against type 2 diabetes by promoting PPAR\u03b3\u2013FGF21\u2013GLUT2-regulated insulin sensitivity and glucose\/lipid homeostasis","volume":"218","author":"Chen","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.018_bib76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jcp.30499","article-title":"Fetuin-A excess expression amplifies lipid induced apoptosis and \u03b2-cell damage","volume":"237","author":"Mukhuty","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib77","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00125-021-05435-1","article-title":"The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells","volume":"64","author":"Gerst","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167047","article-title":"Vildagliptin inhibits high fat and fetuin-A mediated DPP-4 expression, intracellular lipid accumulation and improves insulin secretory defects in pancreatic beta cells","volume":"1870","author":"Nag","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.01.018_bib79","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00257.2024","article-title":"Secreted GDF15 maintains transcriptional responses during DNA damage-mediated senescence in human beta cells","volume":"327","author":"Rampazzo","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib80","doi-asserted-by":"crossref","first-page":"bqac030","DOI":"10.1210\/endocr\/bqac030","article-title":"Deletion of Gdf15 reduces ER stress-induced beta-cell apoptosis and diabetes","volume":"163","author":"Xu","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2026.01.018_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14728222.2022.2029410","article-title":"GDF15: a potential therapeutic target for type 1 diabetes","volume":"26","author":"Sarkar","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.apsb.2026.01.018_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive proteomics analysis of stressed human islets identifies GDF15 as a target for type 1 diabetes intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1037948","article-title":"GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans","volume":"13","author":"Plomgaard","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib84","first-page":"119","article-title":"Selenoprotein P as a significant regulator of pancreatic \u03b2 cell function","volume":"167","author":"Saito","year":"2020","journal-title":"J Biochem"},{"key":"10.1016\/j.apsb.2026.01.018_bib85","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41467-017-01863-z","article-title":"Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models","volume":"8","author":"Mita","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.03.009","article-title":"Role of selenoprotein P expression in the function of pancreatic \u03b2 cells: prevention of ferroptosis-like cell death and stress-induced nascent granule degradation","volume":"183","author":"Kitabayashi","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib87","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cmet.2015.12.001","article-title":"SerpinB1 promotes pancreatic \u03b2 cell proliferation","volume":"23","author":"El","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib88","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/s41467-025-57167-0","article-title":"Liver-derived Neuregulin1\u03b1 stimulates compensatory pancreatic \u03b2 cell hyperplasia in insulin resistance","volume":"16","author":"Arai","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13045-021-01161-8","article-title":"Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target","volume":"14","author":"Qian","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.01.018_bib90","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/medicina58121753","article-title":"Fibrinogen-like protein 1 as a predictive marker for the incidence of severe acute pancreatitis and infectious pancreatic necrosis","volume":"58","author":"Sui","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.apsb.2026.01.018_bib91","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/biom11030370","article-title":"Eicosapentaenoic acid inhibits KRAS mutant pancreatic cancer cell growth by suppressing hepassocin expression and STAT3 phosphorylation","volume":"11","author":"Chiu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.01.018_bib92","article-title":"LECT 2 antagonizes FOXM1 signaling via inhibiting MET to retard PDAC progression","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.01.018_bib93","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.18632\/aging.202403","article-title":"Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.apsb.2026.01.018_bib94","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.7150\/ijbs.61717","article-title":"Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor","volume":"17","author":"Zhou","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib95","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1038\/s41598-020-64920-6","article-title":"Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system","volume":"10","author":"Nakahodo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.01.018_bib96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S2213-8587(23)00001-3","article-title":"Mechanisms of ageing: growth hormone, dietary restriction, and metformin","volume":"11","author":"Khan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib97","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/db08-0551","article-title":"Beta-cell hyperplasia induced by hepatic insulin resistance: role of a liver\u2013pancreas endocrine axis through insulin receptor A isoform","volume":"58","author":"Escribano","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib98","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1210\/en.2012-1496","article-title":"Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms","volume":"153","author":"Ara\u00fajo","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2026.01.018_bib99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(01)01352-8","article-title":"Hepatocyte growth factor attenuates pancreatic damage in caerulein-induced pancreatitis in rats","volume":"430","author":"Warzecha","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.018_bib100","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/diabetes.54.7.2090","article-title":"Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass","volume":"54","author":"Roccisana","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib101","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/db13-0333","article-title":"Hepatocyte growth factor\/c-Met signaling is required for \u03b2-cell regeneration","volume":"63","author":"Alvarez-Perez","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153740","article-title":"HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis","volume":"8","author":"Sargsyan","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.01.018_bib103","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/bjc.2015.478","article-title":"Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer","volume":"114","author":"Pothula","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2026.01.018_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104352","article-title":"Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition","volume":"86","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2026.01.018_bib105","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jhep.2022.03.005","article-title":"Long-term albumin treatment in patients with cirrhosis and ascites","volume":"76","author":"Caraceni","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03449-8","article-title":"Hypoalbuminemia affects one third of acute pancreatitis patients and is independently associated with severity and mortality","volume":"11","author":"Ocskay","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.01.018_bib107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12876-023-02801-8","article-title":"Albumin infusion may decrease the mortality of hypoalbuminemia patients with severe acute pancreatitis: a retrospective cohort study","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib108","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbrc.2009.11.112","article-title":"Albumin mediates PPAR-gamma or C\/EBP-alpha-induced phenotypic changes in pancreatic stellate cells","volume":"391","author":"Kim","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib109","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gut.2008.170233","article-title":"Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin","volume":"58","author":"Kim","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.01.018_bib110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.lfs.2011.02.022","article-title":"Effects of human serum albumin complexed with free fatty acids on cell viability and insulin secretion in the hamster pancreatic \u03b2-cell line HIT-T15","volume":"88","author":"Tuei","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib111","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.kint.2017.08.033","article-title":"Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus","volume":"93","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.apsb.2026.01.018_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1282015","article-title":"Association between blood urea nitrogen levels and the risk of diabetes mellitus in Chinese adults: secondary analysis based on a multicenter, retrospective cohort study","volume":"15","author":"Du","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib113","first-page":"F786","article-title":"Urea-associated oxidative stress and Gadd153\/CHOP induction","volume":"276","author":"Zhang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib114","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"D'Apolito","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.01.018_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.apsb.2026.01.018_bib116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2015.01.034","article-title":"Urea-induced ROS cause endothelial dysfunction in chronic renal failure","volume":"239","author":"D'Apolito","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.01.018_bib117","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1172\/JCI86181","article-title":"Urea impairs \u03b2 cell glycolysis and insulin secretion in chronic kidney disease","volume":"126","author":"Koppe","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.01.018_bib118","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41551-020-0582-1","article-title":"An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure","volume":"4","author":"Zheng","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.018_bib119","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s42255-020-0199-4","article-title":"Glucose-dependent partitioning of arginine to the urea cycle protects \u03b2-cells from inflammation","volume":"2","author":"Fu","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109298","article-title":"Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release","volume":"35","author":"Geisler","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.01.018_bib121","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cmet.2014.03.005","article-title":"Glucagon regulates hepatic kisspeptin to impair insulin secretion","volume":"19","author":"Song","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib122","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib123","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ibd\/izaa342","article-title":"Alterations in bile acid metabolism associated with inflammatory bowel disease","volume":"27","author":"Li","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.apsb.2026.01.018_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MPA.0000000000001706","article-title":"Role of bile acids and bile salts in acute pancreatitis: from the experimental to clinical studies","volume":"50","author":"Tran","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.apsb.2026.01.018_bib125","doi-asserted-by":"crossref","first-page":"G193","DOI":"10.1152\/ajpgi.00317.2015","article-title":"A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury","volume":"310","author":"Katona","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib126","doi-asserted-by":"crossref","first-page":"G875","DOI":"10.1152\/ajpgi.00558.2005","article-title":"Phosphatidylinositol 3-kinase facilitates bile acid-induced Ca2+ responses in pancreatic acinar cells","volume":"292","author":"Fischer","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib127","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2009.10.052","article-title":"Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1","volume":"138","author":"Perides","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib128","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.gastro.2011.02.054","article-title":"Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells","volume":"140","author":"Booth","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature12811","article-title":"Structural basis of the alternating-access mechanism in a bile acid transporter","volume":"505","author":"Zhou","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.018_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.01.018_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100057","article-title":"Recent insights about autophagy in pancreatitis","volume":"2","author":"Ding","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcmgh.2014.11.002","article-title":"Acinar cell production of leukotriene B(4) contributes to development of neurogenic pancreatitis in mice","volume":"1","author":"Shahid","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib133","doi-asserted-by":"crossref","first-page":"G1423","DOI":"10.1152\/ajpgi.00546.2011","article-title":"Ryanodine receptors contribute to bile acid-induced pathological calcium signaling and pancreatitis in mice","volume":"302","author":"Husain","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib134","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-015-0107-9","article-title":"Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells","volume":"13","author":"Kowal","year":"2015","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2026.01.018_bib135","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2019.06.124","article-title":"Hepatocytes derived extracellular vesicles from high-fat diet induced obese mice modulate genes expression and proliferation of islet \u03b2 cells","volume":"516","author":"Fu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib136","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/liv.15654","article-title":"Steatotic hepatocyte-derived extracellular vesicles promote \u03b2-cell apoptosis and diabetes via microRNA-126a-3p","volume":"43","author":"Chen","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.01.018_bib137","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s42255-021-00444-1","article-title":"Hepatocyte-derived exosomes from early onset obese mice promote insulin sensitivity through miR-3075","volume":"3","author":"Ji","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib138","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00125-025-06445-z","article-title":"Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: essential role of macrophage TLR4 in beta cell functionality","volume":"68","author":"Al\u00e9n","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib139","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42255-023-00971-z","article-title":"Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication","volume":"6","author":"Miotto","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1196831","article-title":"Role of extracellular vesicles in nonalcoholic fatty liver disease","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib141","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2026.01.018_bib142","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1815150116","article-title":"PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin","volume":"116","author":"Besse-Patin","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.018_bib143","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1152\/physrev.00028.2023","article-title":"Hepatic glucagon action: beyond glucose mobilization","volume":"104","author":"Kajani","year":"2024","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib144","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/dbi22-0004","article-title":"The Liver\u2013\u03b1-cell axis in health and in disease","volume":"71","author":"Richter","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/db19-0715","article-title":"Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis","volume":"69","author":"Suppli","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154802","article-title":"Molecular mechanisms underlying hepatitis C virus infection-related diabetes","volume":"121","author":"Ding","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2026.01.018_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.112063","article-title":"An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC)","volume":"578","author":"Ferreira","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib148","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/endrev\/bnae022","article-title":"Structure and function of somatostatin and its receptors in endocrinology","volume":"46","author":"Zhang","year":"2025","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10296-z","article-title":"Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls","volume":"7","author":"Henquin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.01.018_bib150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF03347281","article-title":"Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men","volume":"21","author":"Peracchi","year":"1998","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.apsb.2026.01.018_bib151","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/ijms20102512","article-title":"Somatostatin and the \u201csmall-for-size\u201d liver","volume":"20","author":"Hessheimer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib152","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MOG.0b013e328343433f","article-title":"Somatostatin analogues for treatment of polycystic liver disease","volume":"27","author":"Gevers","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib153","article-title":"Effect of octreotide on hepatic steatosis in diet-induced obesity in rats","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.01.018_bib154","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1572-0241.2007.01262.x","article-title":"A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study","volume":"102","author":"Spahr","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.01.018_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170923","article-title":"Pancreatic polypeptide revisited: potential therapeutic effects in obesity\u2013diabetes","volume":"160","author":"Zhu","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2026.01.018_bib156","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jc.2014-3450","article-title":"Circulating pancreatic polypeptide concentrations predict visceral and liver fat content","volume":"100","author":"Sam","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib157","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9610(99)80117-2","article-title":"Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide","volume":"169","author":"Seymour","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.apsb.2026.01.018_bib158","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/jsre.1998.5284","article-title":"Overexpression of hepatic pancreatic polypeptide receptors in chronic pancreatitis","volume":"76","author":"Seymour","year":"1998","journal-title":"J Surg Res"},{"key":"10.1016\/j.apsb.2026.01.018_bib159","doi-asserted-by":"crossref","first-page":"eaay5186","DOI":"10.1126\/scitranslmed.aay5186","article-title":"Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy","volume":"12","author":"Hernandez","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib160","first-page":"515","article-title":"Effects of central FGF21 infusion on the glucose homeostasis in rats (brain\u2013pancreas axis)","volume":"130","author":"Tanbek","year":"2024","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.apsb.2026.01.018_bib161","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2016.12.004","article-title":"FGF21 is an exocrine pancreas secretagogue","volume":"25","author":"Coate","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib162","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/dom.16089","article-title":"The role of the glucagon\u2013FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition","volume":"27","author":"Moreno-Lopez","year":"2025","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.apsb.2026.01.018_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148252","article-title":"Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas","volume":"11","author":"Singhal","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.01.018_bib164","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2016-1681","article-title":"Exercise-induced secretion of FGF21 and follistatin are blocked by pancreatic clamp and impaired in type 2 diabetes","volume":"101","author":"Hansen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib165","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/mt.2015.29","article-title":"Overcoming insulin insufficiency by forced follistatin expression in \u03b2-cells of db\/db mice","volume":"23","author":"Zhao","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.01.018_bib166","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1753-4887.2011.00457.x","article-title":"Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic \u03b2 cells and liver","volume":"70","author":"Wang","year":"2012","journal-title":"Nutr Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib167","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2337\/db09-1552","article-title":"Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function","volume":"59","author":"Robert-Cooperman","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib168","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.24295","article-title":"Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib169","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/diab.41.8.975","article-title":"In vitro effects of amylin on carbohydrate metabolism in liver cells","volume":"41","author":"Ciaraldi","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib170","article-title":"Amylin and calcitonin: potential therapeutic strategies to reduce body weight and liver fat","volume":"11","author":"Mathiesen","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib171","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib172","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/dom.13023","article-title":"Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates","volume":"19","author":"Kim","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.apsb.2026.01.018_bib173","article-title":"AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients","volume":"1","author":"Kaufman","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.12.011","article-title":"Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist","volume":"35","author":"Benichou","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/oncolo\/oyad002","article-title":"Phase Ib and expansion study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with metastatic pancreatic cancer","volume":"28","author":"Perez","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.apsb.2026.01.018_bib176","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in patients with obesity and type 2 diabetes: results from a randomized phase 2 study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.apsb.2026.01.018_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.04.011","article-title":"Pegbelfermin in patients with nonalcoholic steatohepatitis and stage 3 fibrosis (FALCON 1): a randomized phase 2b study","volume":"22","author":"Loomba","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib178","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","article-title":"Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"27","author":"Harrison","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib179","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib180","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2026.01.018_bib181","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2026.01.018_bib182","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002442","article-title":"GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes","volume":"9","author":"Espes","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.apsb.2026.01.018_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150733","article-title":"A proof of concept, phase II randomized European trial, on the efficacy of ALF-5755, a novel extracellular matrix-targeted antioxidant in patients with acute liver diseases","volume":"11","author":"Nalpas","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.01.018_bib184","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib185","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.2337\/dc12-2012","article-title":"Dual peroxisome proliferator-activated receptor \u03b1\/\u03b4 agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects","volume":"36","author":"Cariou","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2026.01.018_bib186","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/cts.12977","article-title":"Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor","volume":"14","author":"Kessler","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.apsb.2026.01.018_bib187","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4187796","article-title":"Beneficial effects of ursodeoxycholic acid on metabolic parameters and oxidative stress in patients with type 2 diabetes mellitus: a randomized double-blind, placebo-controlled clinical study","volume":"2024","author":"Laki\u0107","year":"2024","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.apsb.2026.01.018_bib188","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dia.2006.0013","article-title":"Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight","volume":"9","author":"Karl","year":"2007","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.apsb.2026.01.018_bib189","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3810\/pgm.2013.05.2635","article-title":"Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy","volume":"125","author":"Herrmann","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.apsb.2026.01.018_bib190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide-semaglutide in adults with overweight or obesity and type 2 diabetes","volume":"393","author":"Davies","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib191","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.018_bib192","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/liv.16020","article-title":"Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: post hoc analysis of the ANSWER trial","volume":"44","author":"Pompili","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.01.018_bib193","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.3A0815-371RRR","article-title":"Reg3g overexpression promotes \u03b2 cell regeneration and induces immune tolerance in nonobese-diabetic mouse model","volume":"99","author":"Xia","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2026.01.018_bib194","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/bph.15803","article-title":"Regenerating islet-derived protein 3 gamma (Reg3g) ameliorates tacrolimus-induced pancreatic \u03b2-cell dysfunction in mice by restoring mitochondrial function","volume":"179","author":"Li","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.018_bib195","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00132.2024","article-title":"Intraduodenal administration of Reg3g improves gut barrier function and mitigates hepatic steatosis in mice","volume":"328","author":"Shin","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib196","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.2147\/IJN.S318331","article-title":"Identification of novel ligands for targeted antifibrotic therapy of chronic pancreatitis","volume":"16","author":"Hung","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.01.018_bib197","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1091-255X(01)00071-3","article-title":"Pancreatic elastase induces liver injury by activating cytokine production within Kupffer cells via nuclear factor-Kappa B","volume":"6","author":"Murr","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.apsb.2026.01.018_bib198","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/nm.3705","article-title":"Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress","volume":"20","author":"Hasnain","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib199","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1038\/s41467-024-48317-x","article-title":"Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Sajiir","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib200","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1073\/pnas.0804091105","article-title":"Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice","volume":"105","author":"Sennello","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.018_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12055","article-title":"Pancreatic \u03b2 cells control glucose homeostasis via the secretion of exosomal miR-29 family","volume":"10","author":"Li","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.01.018_bib202","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2026.01.018_bib203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.018_bib204","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/me.2015-1007","article-title":"An acetate-specific GPCR, FFAR2, regulates insulin secretion","volume":"29","author":"Priyadarshini","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107041","article-title":"Effects of short-chain fatty acids on blood glucose and lipid levels in mouse models of diabetes mellitus: a systematic review and network meta-analysis","volume":"199","author":"Zheng","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.01.018_bib206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pan.2019.01.021","article-title":"Short chain fatty acids, pancreatic dysfunction and type 2 diabetes","volume":"19","author":"Mandaliya","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib207","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1021\/jf900470c","article-title":"Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation","volume":"57","author":"Kondo","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2026.01.018_bib208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The bile acid membrane receptor TGR5: a valuable metabolic target","volume":"29","author":"Pols","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.apsb.2026.01.018_bib209","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1152\/ajpendo.00547.2020","article-title":"Peripheral and central regulation of insulin by the intestine and microbiome","volume":"320","author":"Schertzer","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib210","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","article-title":"Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver","volume":"79","author":"Newsome","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib211","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2016.10.001","article-title":"Glucagon-like peptide-1 and the central\/peripheral nervous system: crosstalk in diabetes","volume":"28","author":"Muscogiuri","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib212","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ph18030399","article-title":"Semaglutide as a GLP-1 agonist: a breakthrough in obesity treatment","volume":"18","author":"Salvador","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2026.01.018_bib213","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00125-017-4289-0","article-title":"Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Kapitza","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib214","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2024.02.022","article-title":"Safety and efficacy of efruxifermin in combination with a GLP-1 receptor agonist in patients with NASH\/MASH and type 2 diabetes in a randomized phase 2 study","volume":"23","author":"Harrison","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.01.018_bib215","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54080-w","article-title":"The dual GLP-1\/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk","volume":"15","author":"Valdecantos","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib216","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib217","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib218","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib219","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","volume":"402","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.018_bib221","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib222","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-017-01869-7","article-title":"Neuronal signals regulate obesity induced \u03b2-cell proliferation by FoxM1 dependent mechanism","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib223","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41551-023-01113-2","article-title":"Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and \u03b2 cell proliferation","volume":"8","author":"Kawana","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.018_bib224","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.183864","article-title":"Colonic inflammation triggers \u03b2 cell proliferation during obesity development via a liver-to-pancreas interorgan mechanism","volume":"10","author":"Kubo","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.01.018_bib225","doi-asserted-by":"crossref","first-page":"E786","DOI":"10.1152\/ajpendo.00202.2010","article-title":"Vagal control of pancreatic \u03b2-cell proliferation","volume":"299","author":"Lausier","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib226","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1507\/endocrj.EJ12-0361","article-title":"Involvement of the parasympathetic nervous system in the initiation of regeneration of pancreatic \u03b2-cells","volume":"60","author":"Medina","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.apsb.2026.01.018_bib227","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1038\/s41467-018-07747-0","article-title":"Vagus\u2013macrophage\u2013hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation","volume":"9","author":"Izumi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib228","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/hep.32055","article-title":"Hepatic nervous system in development, regeneration, and disease","volume":"74","author":"Miller","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.01.018_bib229","doi-asserted-by":"crossref","first-page":"507","DOI":"10.15171\/apb.2017.063","article-title":"Cholinergic anti-inflammatory pathway and the liver","volume":"7","author":"Hajiasgharzadeh","year":"2017","journal-title":"Adv Pharmaceut Bull"},{"key":"10.1016\/j.apsb.2026.01.018_bib230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/CM9.0000000000003104","article-title":"Vagus nerve modulates acute-on-chronic liver failure progression via CXCL9","volume":"138","author":"Wu","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.apsb.2026.01.018_bib231","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1113\/JP278567","article-title":"Restoring the autonomic balance to reduce liver steatosis","volume":"597","author":"Bruinstroop","year":"2019","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib232","article-title":"The sympathetic-immune milieu in metabolic health and diseases: insights from pancreas, liver, intestine, and adipose tissues","volume":"11","author":"Ren","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2026.01.018_bib233","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/en.2016-1662","article-title":"Knockdown of neuropeptide Y in the dorsomedial hypothalamus promotes hepatic insulin sensitivity in male rats","volume":"157","author":"Li","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2026.01.018_bib234","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1038\/s41467-020-20160-w","article-title":"Optogenetic stimulation of the liver-projecting melanocortinergic pathway promotes hepatic glucose production","volume":"11","author":"Kwon","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.018_bib235","doi-asserted-by":"crossref","first-page":"dmm049612","DOI":"10.1242\/dmm.049612","article-title":"Involvement of the liver\u2013gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A","volume":"15","author":"Owaki","year":"2022","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.apsb.2026.01.018_bib236","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.00250.2016","article-title":"Kupffer cells facilitate the acute effects of leptin on hepatic lipid metabolism","volume":"312","author":"Metlakunta","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib237","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1073\/pnas.0909422107","article-title":"Leptin therapy in insulin-deficient type I diabetes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.018_bib238","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating miRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.018_bib239","doi-asserted-by":"crossref","first-page":"12158","DOI":"10.1073\/pnas.1808855115","article-title":"Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice","volume":"115","author":"Casta\u00f1o","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.018_bib240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ebiom.2016.12.002","article-title":"MicroRNAs 106b and 222 improve hyperglycemia in a mouse model of insulin-deficient diabetes via pancreatic \u03b2-cell proliferation","volume":"15","author":"Tsukita","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2026.01.018_bib241","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00125-016-3900-0","article-title":"Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK\/p53-dependent pathway","volume":"59","author":"Lu","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib242","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.gastro.2025.03.033","article-title":"Metabolic dysfunction-associated steatohepatitis adipose tissue macrophages secrete extracellular vesicles that activate liver fibrosis in obese male mice","volume":"169","author":"Rohm","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.01.018_bib243","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nm.3549","article-title":"Protectin DX alleviates insulin resistance by activating a myokine\u2013liver glucoregulatory axis","volume":"20","author":"White","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib244","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1096\/fj.14-264820","article-title":"Exercise increases pancreatic \u03b2-cell viability in a model of type 1 diabetes through IL-6 signaling","volume":"29","author":"Paula","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.01.018_bib245","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib246","doi-asserted-by":"crossref","first-page":"30335","DOI":"10.1073\/pnas.2016112117","article-title":"Delivery of muscle-derived exosomal miRNAs induced by HIIT improves insulin sensitivity through down-regulation of hepatic FoxO1 in mice","volume":"117","author":"Casta\u00f1o","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.018_bib247","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00125-016-3882-y","article-title":"Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice","volume":"59","author":"Jalabert","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.01.018_bib248","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib249","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db17-0002","article-title":"The myokine irisin is released in response to saturated fatty acids and promotes pancreatic \u03b2-cell survival and insulin secretion","volume":"66","author":"Natalicchio","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.01.018_bib250","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1074\/mcp.M114.039651","article-title":"Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance","volume":"14","author":"Yoon","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.apsb.2026.01.018_bib251","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1152\/ajpendo.00353.2017","article-title":"Do skeletal muscle-secreted factors influence the function of pancreatic \u03b2-cells?","volume":"314","author":"Barlow","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib252","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.apsb.2026.01.018_bib253","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.01.018_bib255","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib256","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.01.018_bib257","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bcp.2013.08.015","article-title":"Bile acid receptors in non-alcoholic fatty liver disease","volume":"86","author":"Li","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.018_bib258","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/jm049904b","article-title":"Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure\u2013activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid","volume":"47","author":"Pellicciari","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.01.018_bib259","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib260","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fendo.2014.00224","article-title":"IGF-IR targeted therapy: past, present and future","volume":"5","author":"Janssen","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib261","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","article-title":"Exerkines in health, resilience and disease","volume":"18","author":"Chow","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2026.01.018_bib262","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.018_bib263","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2026.01.018_bib264","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/clinem\/dgae550","article-title":"A growth sifferentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons","volume":"110","author":"Smith","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.01.018_bib265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/1535-7163.MCT-20-0625","article-title":"Redundant signaling as the predominant mechanism for resistance to antibodies targeting the type-I insulin-like growth factor receptor in cells derived from childhood sarcoma","volume":"22","author":"Shackleford","year":"2023","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2026.01.018_bib266","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12893-020-00739-2","article-title":"Hypoalbuminemia after pancreaticoduodenectomy does not predict or affect short-term postoperative prognosis","volume":"20","author":"Xu","year":"2020","journal-title":"BMC Surg"},{"key":"10.1016\/j.apsb.2026.01.018_bib267","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2026.01.018_bib268","article-title":"Multi-target approaches in metabolic syndrome","volume":"11","author":"Lillich","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.018_bib269","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13098-023-01198-4","article-title":"Efficacy and safety of tirzepatide, dual GLP-1\/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Zhou","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.apsb.2026.01.018_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155912","article-title":"Deciphering the molecular pathways of saroglitazar: a dual PPAR \u03b1\/\u03b3 agonist for managing metabolic NAFLD","volume":"155","author":"Ezhilarasan","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2026.01.018_bib271","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.3390\/ijms26146996","article-title":"AI-driven polypharmacology in small-molecule drug discovery","volume":"26","author":"Abdelsayed","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:49:53Z","timestamp":1776196193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":271,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2211383526000407"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.01.018","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver\u2013pancreas communication in disease and drug development","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}